學術活動
2024.11.23 | by 秘書處 秘書處
南區大腸直腸腫瘤醫學研討會
南區大腸直腸腫瘤醫學研討會
日期:2024/11/23,下午03:30~2024/11/24,上午11:00
地點:嘉義 新悅花園酒店(嘉義市東區後湖里保順路69號)
【實體課程介紹】
Colorectal cancer (CRC) is a prevalent malignancy with diverse treatment approaches based on disease stage and patient needs. In the seminar, we discussed the current status of stage II CRC treatment, emphasizing the benefits of adjuvant chemotherapy for low-risk patients. For metastatic colorectal cancer (mCRC), the focus was on optimizing Bevacizumab use to maximize patient benefits. Additionally, we examined the analysis of Taiwan's Health Insurance Database, highlighting the benefits of Lonsurf in combination therapy, and shared real-world hospital experiences demonstrating its efficacy. The seminar also covered the latest developments in peritoneal metastasis treatment with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), discussing applicable cancer types, costs, survival rates, and side effects. Finally, advancements in endoscopic techniques, such as the evolution from endoscopic submucosal dissection (ESD) to endoscopic full-thickness resection (EFTR), were reviewed, with a focus on their clinical applications, advantages, and limitations in CRC treatment.
主辦/課程洽詢:
高雄市胃腸道腫瘤關懷協會
07-3121101分機5575
1130223@mail.kmuh.org.tw
積分:
本會醫師 10分
日期:2024/11/23,下午03:30~2024/11/24,上午11:00
地點:嘉義 新悅花園酒店(嘉義市東區後湖里保順路69號)
【實體課程介紹】
Colorectal cancer (CRC) is a prevalent malignancy with diverse treatment approaches based on disease stage and patient needs. In the seminar, we discussed the current status of stage II CRC treatment, emphasizing the benefits of adjuvant chemotherapy for low-risk patients. For metastatic colorectal cancer (mCRC), the focus was on optimizing Bevacizumab use to maximize patient benefits. Additionally, we examined the analysis of Taiwan's Health Insurance Database, highlighting the benefits of Lonsurf in combination therapy, and shared real-world hospital experiences demonstrating its efficacy. The seminar also covered the latest developments in peritoneal metastasis treatment with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), discussing applicable cancer types, costs, survival rates, and side effects. Finally, advancements in endoscopic techniques, such as the evolution from endoscopic submucosal dissection (ESD) to endoscopic full-thickness resection (EFTR), were reviewed, with a focus on their clinical applications, advantages, and limitations in CRC treatment.
主辦/課程洽詢:
高雄市胃腸道腫瘤關懷協會
07-3121101分機5575
1130223@mail.kmuh.org.tw
積分:
本會醫師 10分
【附件下載】
TOP